These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4589208)

  • 1. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J
    Postepy Hig Med Dosw; 1973; 27(6):725-80. PubMed ID: 4589208
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Hyperthermia in rabbits caused by interaction between M.A.O.I.s, antiparkinson drugs, and neuroleptics.
    Pedersen V; Nielsen IM
    Lancet; 1975 Aug; 2(7931):409-10. PubMed ID: 51215
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanism of action of neuroleptics and antidepressive drugs].
    Carlsson A
    Lakartidningen; 1965 Jun; 62(25):1978-90. PubMed ID: 5869564
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of neuroleptics and nialamide on defensive conditoned reflex in rats.
    Plech S; Drybański A; Herman Z
    Acta Physiol Pol; 1975; 26(3):255-60. PubMed ID: 1180066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PS-2747: a new antidepressant agent.
    Plotnikoff N; Will F; Evans A; Meekma P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):330-42. PubMed ID: 4622667
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the functional role of intraneuronal monamine oxidase.
    Clarke DE; Sampath SS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):539-49. PubMed ID: 4770399
    [No Abstract]   [Full Text] [Related]  

  • 9. The therapeutic potential of monoamine oxidase inhibitors.
    Youdim MB; Edmondson D; Tipton KF
    Nat Rev Neurosci; 2006 Apr; 7(4):295-309. PubMed ID: 16552415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia.
    Ban TA; Lehmann HE; Klingner A
    Int J Clin Pharmacol; 1973 Feb; 7(1):44-7. PubMed ID: 4699383
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of neuroleptics on endogenous norepinephrine in rat brain.
    Bartholini G; Keller HH; Pletscher A
    Neuropharmacology; 1973 Aug; 12(8):751-6. PubMed ID: 4746440
    [No Abstract]   [Full Text] [Related]  

  • 12. The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase.
    Vetulani J
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):501-6. PubMed ID: 4730817
    [No Abstract]   [Full Text] [Related]  

  • 13. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interactions between drugs used in anesthesia-resuscitation in the pre-, per- and postoperative stages and various types of drugs].
    Lareng L
    Minerva Anestesiol; 1972 Feb; 38(2):81-125. PubMed ID: 4151745
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of amine oxidase inhibitors, vasodilator and tranquilizing agents on experimental isoproterenol-induced myocardial necrosis].
    ZBINDEN G
    Arzneimittelforschung; 1962 Jun; 12():635-8. PubMed ID: 14009960
    [No Abstract]   [Full Text] [Related]  

  • 17. Central and peripheral dopamine beta hydroxylase: responses to long term treatment with monoamine oxidase inhibitors.
    Lerner P; Major LF; Dendel PS; Campbell IC; Murphy DL
    Neuropharmacology; 1980 Sep; 19(9):877-81. PubMed ID: 7422098
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents.
    Costall B; Naylor RJ; Wright T
    Arzneimittelforschung; 1972 Jul; 22(7):1178-83. PubMed ID: 4404343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.